Q32 Bio Inc. Payments to Acquire Debt Securities, Available-for-sale
Q32 Bio Inc. (FIXX) reported Payments to Acquire Debt Securities, Available-for-sale of $73.24 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2024-03-13
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2023-12-31 was $0.00.
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2023-09-30 was $47.96M, a 55.68% decline year-over-year.
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2023-06-30 was -$1.00K, a 100.00% decline year-over-year.
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2023-03-31 was $25.28M.
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $73.24M, a 53.49% decline from fiscal 2022.
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $157.46M, a 61.68% increase from fiscal 2021.
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for fiscal 2021 was $97.39M, a 387.18% increase from fiscal 2020.
- Q32 Bio Inc. payments to acquire debt securities, available-for-sale for fiscal 2020 was $19.99M, a 93.02% decline from fiscal 2019.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 3 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 6 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 9 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $47.96M derived: sum of 2 quarters · filed 2024-03-13 | $47.96M derived: sum of 3 quarters · filed 2024-03-13 | $73.24M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $47.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $47.96M derived: sum of 2 quarters · filed 2023-11-14 | $73.24M 10-Q · filed 2023-11-14 | $73.24M derived: sum of 4 quarters · filed 2024-03-13 | |||
| 2023-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $25.28M 10-Q · filed 2023-08-14 | $25.28M derived: sum of 3 quarters · filed 2024-03-13 | $133.49M derived: sum of 4 quarters · filed 2024-03-13 | |||
| 2023-03-31 | $25.28M 10-Q · filed 2023-05-11 | $25.28M derived: sum of 2 quarters · filed 2024-03-13 | $133.50M derived: sum of 3 quarters · filed 2024-03-13 | $182.74M derived: sum of 4 quarters · filed 2024-03-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $108.21M derived: sum of 2 quarters · filed 2024-03-13 | $157.46M derived: sum of 3 quarters · filed 2024-03-13 | $157.46M 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $108.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $157.46M derived: sum of 2 quarters · filed 2023-11-14 | $157.46M 10-Q · filed 2023-11-14 | $157.46M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $49.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $49.25M 10-Q · filed 2023-08-14 | $49.25M derived: sum of 3 quarters · filed 2023-08-14 | $49.25M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $1.00K derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | $12.97M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $12.97M derived: sum of 3 quarters · filed 2023-03-09 | $97.39M 10-K · filed 2023-03-09 | |||
| 2021-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $12.97M derived: sum of 2 quarters · filed 2022-11-10 | $97.39M 10-Q · filed 2022-11-10 | $97.39M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $12.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $97.39M 10-Q · filed 2022-08-15 | $97.39M derived: sum of 3 quarters · filed 2022-08-15 | $97.39M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $84.42M 10-Q · filed 2022-05-16 | $84.42M derived: sum of 2 quarters · filed 2022-05-16 | $84.42M derived: sum of 3 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$1.00K derived: sum of 2 quarters · filed 2022-03-23 | $19.99M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $19.99M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $19.99M 10-Q · filed 2021-08-12 | ||||||
| 2019-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $96.92M derived: sum of 2 quarters · filed 2021-03-11 | $201.92M derived: sum of 3 quarters · filed 2021-03-11 | $286.39M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $67.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $172.92M derived: sum of 2 quarters · filed 2020-11-09 | $257.39M 10-Q · filed 2020-11-09 | $270.26M derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $105.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $189.47M 10-Q · filed 2020-08-10 | $202.34M derived: sum of 3 quarters · filed 2020-08-10 | $291.03M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $84.47M 10-Q · filed 2020-05-07 | $97.33M derived: sum of 2 quarters · filed 2020-05-07 | $186.03M derived: sum of 3 quarters · filed 2020-05-07 | $311.20M derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | $12.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $101.56M derived: sum of 2 quarters · filed 2020-03-12 | $226.73M derived: sum of 3 quarters · filed 2020-03-12 | $245.33M 10-K · filed 2020-03-12 | |||
| 2018-09-30 | $88.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $213.87M derived: sum of 2 quarters · filed 2019-11-12 | $232.46M 10-Q · filed 2019-11-12 | $232.46M 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | $125.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $143.77M 10-Q · filed 2019-08-08 | $143.77M 10-Q · filed 2018-08-13 | ||||
| 2018-03-31 | $18.59M 10-Q · filed 2019-05-13 | $18.60M 10-Q · filed 2018-05-14 | |||||
| 2017-12-31 | $78.07M 10-K · filed 2019-03-12 |